The two-part Phase 1/2 trial — dubbed BeCoMe-9 (NCT06611436) — was designed to assess the safety and clinical activity of a ...
To protect her ankles from internal bleeding and pain, columnist G Shellye Horowitz opts for sensible shoes lined with custom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback